Otto C. Boerman

Q: What Schools Are Affiliated With Otto C. Boerman

Otto C. Boerman is affiliated with the following schools: Université catholique de Louvain, Utrecht University, Radboud University Nijmegen

Otto C. Boerman's AcademicInfluence.com Rankings

Otto C. Boerman

Computer Science

#5316

World Rank

#5615

Historical Rank

Machine Learning

#1363

World Rank

#1384

Historical Rank

Artificial Intelligence

#1598

World Rank

#1628

Historical Rank

Database

#2471

World Rank

#2588

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Otto C. Boerman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Otto C. Boerman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy (2005) (810)
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. (2003) (520)
Peritoneal Carcinomatosis of Colorectal Origin: Incidence and Current Treatment Strategies (2006) (476)
Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. (2000) (466)
A Novel Method of 18F Radiolabeling for PET (2009) (326)
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model. (2002) (315)
Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients. (2013) (293)
Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. (2003) (281)
Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. (2001) (267)
Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention (2010) (255)
INTRAVENOUSLY ADMINISTERED SHORT INTERFERING RNA ACCUMULATES IN THE KIDNEY AND SELECTIVELY SUPPRESSES GENE FUNCTION IN RENAL PROXIMAL TUBULES (2006) (214)
Pretargeted radioimmunotherapy of cancer: progress step by step. (2003) (212)
Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. (1996) (203)
Spatial Resolution and Sensitivity of the Inveon Small-Animal PET Scanner (2008) (200)
Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy. (2010) (200)
Biological correlates of FDG uptake in non-small cell lung cancer. (2007) (195)
A Novel Facile Method of Labeling Octreotide with 18F-Fluorine (2010) (190)
PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. (2010) (190)
Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients (2009) (187)
Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial. (2016) (185)
PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status (2015) (180)
Fluorinated amino acids for tumour imaging with positron emission tomography (2002) (179)
Improved targeting of the αvβ3 integrin by multimerisation of RGD peptides (2007) (178)
Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting. (2002) (177)
Imaging of Inflammation by PET, Conventional Scintigraphy, and Other Imaging Techniques (2010) (177)
Sensitive determination of circulating anodic antigen in Schistosoma mansoni infected individuals by an enzyme-linked immunosorbent assay using monoclonal antibodies. (1989) (174)
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250. (1997) (171)
Imaging infection/inflammation in the new millennium (2001) (171)
Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients (2011) (166)
Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. (2005) (166)
Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti-PD-L1 Antibodies. (2015) (164)
18F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors (2010) (163)
Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes. (2007) (160)
Image-Quality Assessment for Several Positron Emitters Using the NEMA NU 4-2008 Standards in the Siemens Inveon Small-Animal PET Scanner (2010) (158)
Incorporation of stromal cell-derived factor-1α in PCL/gelatin electrospun membranes for guided bone regeneration. (2013) (158)
Indication for Different Mechanisms of Kidney Uptake of Radiolabeled Peptides (2007) (158)
Combined delivery of BMP-2 and bFGF from nanostructured colloidal gelatin gels and its effect on bone regeneration in vivo. (2013) (156)
Phenotypical and Functional Characterization of Clinical Grade Dendritic Cells (2002) (150)
Results of ankle fractures with involvement of the posterior tibial margin. (2002) (149)
99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. (2000) (140)
Comparison of micro- vs. nanostructured colloidal gelatin gels for sustained delivery of osteogenic proteins: Bone morphogenetic protein-2 and alkaline phosphatase. (2012) (140)
Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET. (2003) (133)
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET (2010) (131)
Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues (2010) (128)
Non-invasive quantification of the beta cell mass by SPECT with 111In-labelled exendin (2014) (127)
Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re. (2004) (120)
Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250. (1999) (116)
Sterically stabilized liposomes labeled with indium-111 to image focal infection. (1995) (115)
In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin (2006) (115)
Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice (2010) (113)
Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients (2014) (112)
89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry (2017) (111)
Synthesis and comparison of 99mTc-enrofloxacin and 99mTc-ciprofloxacin. (2004) (111)
Tumor Targeting with Radiolabeled v 3 Integrin Binding Peptides in a Nude Mouse Model (2002) (107)
PET imaging of αvβ3 integrin expression in tumours with 68Ga-labelled mono-, di- and tetrameric RGD peptides (2010) (106)
Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice. (2011) (106)
Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose. (2000) (106)
A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative. (1999) (105)
Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats. (2006) (101)
Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. (1999) (100)
Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes. (1996) (98)
Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice. (2003) (97)
Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit? (2014) (97)
Pretargeted Immuno–Positron Emission Tomography Imaging of Carcinoembryonic Antigen–Expressing Tumors with a Bispecific Antibody and a 68Ga- and 18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts (2010) (96)
Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin. (2006) (95)
ImmunoSPECT and ImmunoPET of IGF-1R Expression with the Radiolabeled Antibody R1507 in a Triple-Negative Breast Cancer Model (2010) (95)
Nuclear medicine imaging to predict response to radiotherapy: a review. (2003) (93)
A new technique for in vivo imaging of specific GLP-1 binding sites: First results in small rodents (2006) (93)
PET of Hypoxia with 89Zr-Labeled cG250-F(ab′)2 in Head and Neck Tumors (2010) (93)
Cancer Imaging and Therapy with Bispecific Antibody Pretargeting. (2007) (93)
Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent (2016) (93)
Comparative biodistribution of 12 111In-labelled gastrin/CCK2 receptor-targeting peptides (2011) (89)
The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats. (2008) (89)
Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study (2018) (87)
Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study (2018) (87)
Radiolabeled liposomes for scintigraphic imaging. (2000) (85)
Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin. (2004) (85)
Radiopharmaceuticals to image infection and inflammation. (2001) (85)
Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. (2010) (84)
Radiolabelled peptides for oncological diagnosis (2012) (84)
A Novel 111In-Labeled Anti–Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer (2015) (83)
Application of Metal‐Free Triazole Formation in the Synthesis of Cyclic RGD–DTPA Conjugates (2008) (83)
Correlation of [18F]FMISO autoradiography and pimonodazole immunohistochemistry in human head and neck carcinoma xenografts (2008) (82)
Absolute organ activity estimated by five different methods of background correction. (1998) (82)
Reducing Renal Uptake of Radiolabeled Peptides Using Albumin Fragments (2008) (82)
Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody (2014) (81)
Caffeine prevents protection in two human models of ischemic preconditioning. (2006) (78)
In vitro growth factor release from injectable calcium phosphate cements containing gelatin microspheres. (2009) (78)
Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma. (2005) (78)
Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals. (2000) (77)
Functionalization of multilayered DNA-coatings with bone morphogenetic protein 2. (2006) (76)
Specific imaging of VEGF‐A expression with radiolabeled anti‐VEGF monoclonal antibody (2008) (76)
Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3′-fluoro-3′-deoxy-thymidine ([18F]FLT) PET imaging (2011) (75)
Liposomes as sustained release system for human interferon-gamma: biopharmaceutical aspects. (2001) (75)
Quality of Life in Primary Aldosteronism: A Comparative Effectiveness Study of Adrenalectomy and Medical Treatment (2018) (75)
Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma. (2013) (74)
Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide. (2007) (74)
Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma. (2013) (74)
Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti–Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis (2015) (74)
Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors. (2006) (74)
Pretargeting of renal cell carcinoma: improved tumor targeting with a bivalent chelate. (1999) (73)
Role of fibroblasts in the regulation of proinflammatory interleukin IL-1, IL-6 and IL-8 levels induced by keratinocyte-derived IL-1 (1996) (73)
Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with 18F-Labeled Affibody Molecule ZHER2:2395 in a Mouse Model for Ovarian Cancer (2012) (73)
Comparative Immunohistochemical Study of Four Monoclonal Antibodies Directed Against Ovarian Carcinoma‐Associated Antigens (1991) (72)
Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma. (2013) (71)
Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma. (2013) (71)
Synthesis of DOTA-conjugated multimeric [Tyr3]octreotide peptides via a combination of Cu(I)-catalyzed "click" cycloaddition and thio acid/sulfonyl azide "sulfo-click" amidation and their in vivo evaluation. (2010) (71)
PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats. (2004) (70)
Innovations in Radiotherapy Planning of Head and Neck Cancers: Role of PET (2010) (69)
In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients. (2009) (69)
PET of Tumors Expressing Gastrin-Releasing Peptide Receptor with an 18F-Labeled Bombesin Analog (2012) (67)
Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma (2013) (67)
Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with (131)I or (111)In: an intrapatient comparison. (2003) (67)
Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time. (1997) (67)
Pharmacokinetics, biodistribution and biological effects of intravenously administered bispecific monoclonal antibody OC/TR F(ab′)2 in ovarian carcinoma patients (1996) (66)
Randomized Controlled Trial Comparing Hand-Assisted Retroperitoneoscopic Versus Standard Laparoscopic Donor Nephrectomy (2014) (66)
Optimized labeling of NOTA-conjugated octreotide with F-18 (2011) (65)
In vivo applications of PEG liposomes: unexpected observations. (2001) (65)
Heterophilic antibodies in human sera causing falsely increased results in the CA 125 immunofluorometric assay. (1990) (64)
Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines. (2005) (64)
Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull Mice (2013) (63)
Development of injectable organic/inorganic colloidal composite gels made of self-assembling gelatin nanospheres and calcium phosphate nanocrystals. (2014) (63)
Correlation Between In Vivo 18F-FDG PET and Immunohistochemical Markers of Glucose Uptake and Metabolism in Pheochromocytoma and Paraganglioma (2014) (63)
Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors. (2007) (63)
Enzymosomes with surface-exposed superoxide dismutase: in vivo behaviour and therapeutic activity in a model of adjuvant arthritis. (2007) (62)
Between the Scylla and Charybdis of peptide radionuclide therapy: hitting the tumor and saving the kidney. (2001) (61)
Imaging liver metastases of colorectal cancer patients with radiolabelled bevacizumab: Lack of correlation with VEGF-A expression. (2008) (61)
Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides. (2007) (61)
Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors (2010) (60)
Specific and rapid scintigraphic detection of infection with 99mTc-labeled interleukin-8. (2000) (60)
Continuous vs. intermittent androgen deprivation therapy for metastatic prostate cancer. (2013) (60)
Positron Emission Tomography/Computed Tomography with 89Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion. (2018) (59)
Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis (2012) (59)
131I-cG250 monoclonal antibody immunoscintigraphy versus [18F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study (2002) (59)
Positron Emission Tomography/Computed Tomography with 89Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion. (2018) (59)
αvβ3 Integrin‐targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide (2007) (59)
Oral therapy with dipyridamole limits ischemia‐reperfusion injury in humans (2005) (58)
99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation: first clinical evaluation. (2007) (56)
Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti‐insulin‐like growth factor 1 receptor antibodies (2013) (55)
Radiolabeled cetuximab: Dose optimization for epidermal growth factor receptor imaging in a head‐and‐neck squamous cell carcinoma model (2011) (55)
Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study (2014) (55)
Pretargeted Imaging and Radioimmunotherapy of Cancer Using Antibodies and Bioorthogonal Chemistry (2014) (55)
Application of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes for gene transfer into human ovarian carcinoma cells. (2005) (55)
Theranostic applications of antibodies in oncology (2014) (54)
Preclinical Comparison of Al18F- and 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer (2014) (53)
Radiolabeled interleukin-8: specific scintigraphic detection of infection within a few hours. (2000) (53)
Radiopharmaceuticals for scintigraphic imaging of infection and inflammation (2001) (53)
Tc-99m-PEG-Liposomes for the Evaluation of Colitis in Crohn's Disease (2000) (53)
Bacterial lipopolysaccharide binds and stimulates cytokine-producing cells before neutralization by endogenous lipoproteins can occur. (1998) (52)
Antibody-guided radiation therapy of cancer (2005) (52)
Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation. (2004) (52)
Cryosurgery for prostate cancer: an update on clinical results of modern cryotechnology. (2009) (52)
Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides (2009) (52)
Differential loading methods for BMP-2 within injectable calcium phosphate cement. (2012) (52)
The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma (2014) (51)
Liposomes Containing Interferon-Gamma as Adjuvant in Tumor Cell Vaccines (2004) (51)
Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter Study. (2020) (51)
ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice. (2013) (51)
Microscopic localization of PEG-liposomes in a rat model of focal infection. (2001) (51)
Correlation of [18F]FMISO autoradiography and pimonidazole immunohistochemistry in human head and neck carcinoma xenografts (2008) (51)
Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with 111In in HEPES and MES buffer (2012) (51)
Intraoperative Imaging Techniques to Support Complete Tumor Resection in Partial Nephrectomy. (2017) (50)
Intraoperative Imaging Techniques to Support Complete Tumor Resection in Partial Nephrectomy. (2017) (50)
111In-Bevacizumab Imaging of Renal Cell Cancer and Evaluation of Neoadjuvant Treatment with the Vascular Endothelial Growth Factor Receptor Inhibitor Sorafenib (2010) (50)
Technetium-99m labelled liposomes to image experimental arthritis (1997) (50)
Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammation. (1997) (50)
Analysis of dendritic cell trafficking using EGFP-transgenic mice. (2003) (49)
Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma. (2016) (49)
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity (2016) (49)
Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas. (1991) (49)
SUV: From Silly Useless Value to Smart Uptake Value (2010) (49)
Dosimetric analysis of chimeric monoclonal antibody cMOv18 IgG in ovarian carcinoma patients after intraperitoneal and intravenous administration (1998) (49)
Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma. (2016) (49)
A Novel Method of 18 F Radiolabeling for PET (2009) (48)
Expression and clinical relevance of MET and ALK in Ewing sarcomas (2013) (48)
Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models. (2005) (48)
Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapy. (1999) (48)
Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction (1998) (48)
Rapid imaging of experimental colitis with (99m)Tc-interleukin-8 in rabbits. (2001) (47)
Pretargeted 177Lu Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colonic Tumors in Mice (2010) (47)
Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas. (2012) (47)
Lethal Escherichia coli and Salmonella typhimurium endotoxemia is mediated through different pathways (2001) (47)
Radionuclide imaging of tumor angiogenesis. (2009) (47)
Annexin A5 Scintigraphy of Forearm as a Novel In Vivo Model of Skeletal Muscle Preconditioning in Humans (2005) (47)
Technetium-99m-labeled liposomes to image experimental colitis in rabbits: comparison with technetium-99m-HMPAO-granulocytes and technetium-99m-HYNIC-IgG. (1998) (47)
Development of radiotracers for the determination of the beta-cell mass in vivo. (2010) (46)
Immuno-PET of Cancer: A Revival of Antibody Imaging (2011) (46)
The Effects of Adjuvant Experimental Radioimmunotherapy and Hyperthermic Intraperitoneal Chemotherapy on Intestinal and Abdominal Healing after Cytoreductive Surgery for Peritoneal Carcinomatosis in the Rat (2008) (45)
Diannexin Protects against Renal Ischemia Reperfusion Injury and Targets Phosphatidylserines in Ischemic Tissue (2011) (45)
Subcutaneous Administration of Superoxide Dismutase Entrapped in Long Circulating Liposomes: In Vivo Fate and Therapeutic Activity in an Inflammation Model (2000) (45)
Imaging of Epidermal Growth Factor Receptor Expression in Head and Neck Cancer with SPECT/CT and 111In-Labeled Cetuximab-F(ab′)2 (2013) (45)
Development and application of peptide-based radiopharmaceuticals. (2007) (45)
Radiolabeled compounds in diagnosis of infectious and inflammatory disease. (2004) (45)
Dosimetric Analysis of 177Lu-cG250 Radioimmunotherapy in Renal Cell Carcinoma Patients: Correlation with Myelotoxicity and Pretherapeutic Absorbed Dose Predictions Based on 111In-cG250 Imaging (2012) (45)
Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody (2013) (44)
Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for 89Zr-immunoPET (2019) (44)
Preparation and evaluation of glycosylated arginine-glycine-aspartate (RGD) derivatives for integrin targeting. (2007) (44)
A New Tri-Fab Bispecific Antibody for Pretargeting Trop-2–Expressing Epithelial Cancers (2012) (43)
Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507 (2011) (43)
PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery (2019) (43)
Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma (2019) (43)
(99m)Tc-interleukin-8 for imaging acute osteomyelitis. (2001) (42)
Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats (2008) (42)
Radioimmunotherapy and colorectal cancer (2005) (42)
Experimental radioimmunotherapy of small peritoneal metastases of colorectal origin (2003) (42)
Design of Radioiodinated Pharmaceuticals: Structural Features Affecting Metabolic Stability towards in Vivo Deiodination (2017) (42)
Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection. (1994) (41)
A Comparison Between Radioimmunotherapy and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis of Colonic Origin in Rats (2007) (41)
213Bi-Labeled Prostate-Specific Membrane Antigen-Targeting Agents Induce DNA Double-Strand Breaks in Prostate Cancer Xenografts. (2017) (41)
Al(18) F labeling of peptides and proteins. (2014) (41)
Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy (2017) (41)
Latest Evidence on the Impact of Smoking, Sports, and Sexual Activity as Modifiable Lifestyle Risk Factors for Prostate Cancer Incidence, Recurrence, and Progression: A Systematic Review of the Literature by the European Association of Urology Section of Oncological Urology (ESOU). (2019) (41)
Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer. (2003) (41)
Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection. (2009) (40)
Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection. (2002) (40)
Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-labeled anti-CD20 monoclonal antibody. (2003) (40)
The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: An autoradiographic study (2005) (40)
Dynamic and Static Small-Animal SPECT in Rats for Monitoring Renal Function After 177Lu-Labeled Tyr3-Octreotate Radionuclide Therapy (2010) (40)
Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors. (2004) (40)
Radioimmunotherapy with [131I]cG250 in Patients with Metastasized Renal Cell Cancer: Dosimetric Analysis and Immunologic Response (2005) (40)
Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours (2009) (40)
Labelled Stealth liposomes in experimental infection: an alternative to leukocyte scintigraphy? (1996) (39)
Scintigraphic evaluation of experimental colitis in rabbits. (1997) (39)
Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: current hurdles and future perspectives. (2014) (38)
Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors (2019) (38)
Versatile conjugation of octreotide to dendrimers by cycloaddition ("click") chemistry to yield high-affinity multivalent cyclic Peptide dendrimers. (2009) (38)
Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide. (2013) (38)
Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin αvβ3 (2016) (38)
Drosomycin-Like Defensin, a Human Homologue of Drosophila melanogaster Drosomycin with Antifungal Activity (2008) (38)
In vivo and in vitro studies on renal uptake of radiolabeled affibody molecules for imaging of HER2 expression in tumors. (2013) (37)
Bisphosphonate‐Functionalized Imaging Agents, Anti‐Tumor Agents and Nanocarriers for Treatment of Bone Cancer (2017) (37)
Low‐pressure pneumoperitoneum during laparoscopic donor nephrectomy to optimize live donors’ comfort (2013) (37)
The use of monoclonal antibodies for the treatment of epithelial ovarian cancer (review). (1992) (37)
Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts. (2015) (37)
Surface modifications by gas plasma control osteogenic differentiation of MC3T3-E1 cells. (2012) (37)
SPECT- and Fluorescence Image–Guided Surgery Using a Dual-Labeled Carcinoembryonic Antigen–Targeting Antibody (2014) (37)
In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations. (1999) (36)
Evaluation of an orthotopically implanted calcium phosphate cement containing gelatin microparticles. (2009) (36)
Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis. (2006) (36)
Animal models for liver metastases of colorectal cancer: research review of preclinical studies in rodents. (2009) (35)
Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study (2016) (35)
Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy (2021) (34)
Tyrosine Kinase Inhibitor Sorafenib Decreases 111In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma (2014) (34)
Synthesis and biological evaluation of potent a v h 3 -integrin receptor antagonists (2006) (34)
mTOR Inhibition promotes TTF1-dependent redifferentiation and restores iodine uptake in thyroid carcinoma cell lines. (2014) (34)
Neoadjuvant androgen deprivation for prostate volume reduction: the optimal duration in prostate cancer radiotherapy. (2011) (34)
Imaging experimental intraabdominal abscesses with 99mTc-PEG liposomes and 99mTc-HYNIC IgG. (1999) (34)
Molecular imaging of angiogenesis with SPECT (2010) (34)
Tyrosine Kinase Inhibitor Sorafenib Decreases 111In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma (2014) (34)
Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes. (2007) (34)
Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model (1995) (33)
Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti‐idiotype antibody in tumor‐bearing nude mice (1992) (33)
Detection of Micrometastases Using SPECT/Fluorescence Dual-Modality Imaging in a CEA-Expressing Tumor Model (2017) (33)
Recombinant human IL‐7 administration in mice affects colony‐forming units‐spleen and lymphoid precursor cell localization and accelerates engraftment of bone marrow transplants (1995) (33)
Using the NEMA NU 4 PET Image Quality Phantom in Multipinhole Small-Animal SPECT (2011) (33)
Nephrotoxicity in Mice After Repeated Imaging Using 111In-Labeled Peptides (2010) (33)
Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: Effect of the radionuclide (2003) (32)
Labeling proteins with Tc-99m via hydrazinonicotinamide (HYNIC): optimization of the conjugation reaction. (2000) (32)
Hand-assisted retroperitoneoscopic versus standard laparoscopic donor nephrectomy: HARP-trial (2010) (32)
Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti–Fibroblast Activation Protein Antibody (2017) (32)
The effect of antibody protein dose of anti‐renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts (1997) (32)
Imaging of Prostate Cancer with Immuno-PET and Immuno-SPECT Using a Radiolabeled Anti-EGP-1 Monoclonal Antibody (2011) (32)
89 Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89 Zr Radiochemistry (2017) (31)
New concepts in infection/inflammation imaging. (2001) (31)
1-step versus 2-step immobilization of alkaline phosphatase and bone morphogenetic protein-2 onto implant surfaces using polydopamine. (2013) (31)
Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer (2014) (31)
CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses (2016) (31)
Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: a clinical study. (1998) (30)
Prospects in radionuclide imaging of prostate cancer (2012) (30)
Comparative in vitro binding characteristics and biodistribution in tumor-bearing athymic mice of anti-ovarian carcinoma monoclonal antibodies. (1990) (30)
Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study (2012) (30)
Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts. (1998) (30)
Radionuclide imaging of liposomal drug delivery (2016) (30)
PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging (2015) (30)
PET of EGFR with (64) Cu-cetuximab-F(ab')2 in mice with head and neck squamous cell carcinoma xenografts. (2016) (30)
Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507. (2012) (30)
Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method (2012) (29)
Upregulation of IGF-1R Expression during Neoadjuvant Therapy Predicts Poor Outcome in Breast Cancer Patients (2015) (29)
Imaging of infection in rabbits with radioiodinated interleukin-1 (α and β), its receptor antagonist and a chemotactic peptide: a comparative study (1998) (29)
Cytokine release in an ovarian carcinoma patient following intravenous administration of bispecific antibody OC/TR F(ab')2. (1993) (29)
Porous calcium phosphate cement for alveolar bone regeneration (2014) (29)
Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor-deficient mice (1997) (29)
Tubular reabsorption and local production of urine hepcidin-25 (2013) (29)
Two‐step radio‐immunotargeting of renal‐cell carcinoma xenografts in nude mice with anti‐renal‐cell‐carcinoma X anti‐DTPA bispecific monoclonal antibodies (1998) (29)
α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colon Cancer Xenografts (2017) (28)
111In-exendin Uptake in the Pancreas Correlates With the β-Cell Mass and Not With the α-Cell Mass (2014) (28)
Tumor accumulation of radiolabeled bevacizumab due to targeting of cell- and matrix-associated VEGF-A isoforms. (2009) (28)
Final results of a phase I radioimmunotherapy trial using 186Re-epratuzumab for the treatment of patients with non-Hodgkin's lymphoma (2003) (28)
Animal models of infection and inflammation and their role in experimental nuclear medicine. (2001) (28)
Optical Imaging of Renal Cell Carcinoma with Anti–Carbonic Anhydrase IX Monoclonal Antibody Girentuximab (2014) (27)
Differential susceptibility to lethal endotoxaemia in mice deficient in IL‐1α, IL‐1β or IL‐1 receptor type I (2010) (27)
Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging (2017) (27)
A bivalent leukotriene B(4) antagonist for scintigraphic imaging of infectious foci. (2003) (27)
Imaging Integrin αvβ3 on Blood Vessels with 111In-RGD2 in Head and Neck Tumor Xenografts (2014) (26)
Immunohistochemical analysis of tumor antigen saturation following injection of monoclonal antibody G250. (1999) (26)
Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide. (2007) (26)
Dual contrast agent for computed tomography and magnetic resonance hard tissue imaging. (2013) (26)
Scintigraphic evaluation of experimental chronic osteomyelitis. (2000) (26)
Monoclonal antibody-based therapy for renal cell carcinoma. (2003) (25)
In vivo imaging of therapy-induced anti-cancer immune responses in humans (2012) (25)
Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters (2015) (25)
Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma. (1995) (25)
Pheochromocytoma and Pregnancy. (2019) (25)
PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer (2018) (25)
Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology. (2019) (25)
Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene. (2007) (25)
Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer. (2014) (25)
Surgical Management of Adrenocortical Carcinoma: Impact of Laparoscopic Approach, Lymphadenectomy, and Surgical Volume on Outcomes-A Systematic Review and Meta-analysis of the Current Literature. (2016) (25)
Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma. (2003) (25)
Targeting of a CCK2 receptor splice variant with 111In-labelled cholecystokinin-8 (CCK8) and 111In-labelled minigastrin (2008) (25)
[(18)]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis. (2015) (24)
Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies. (2004) (24)
Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models (2014) (24)
The kinetics of radiolabelled interleukin-8 in infection and sterile inflammation. (1998) (24)
Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin (2016) (24)
Transforming growth factor-beta1 release from a porous electrostatic spray deposition-derived calcium phosphate coating. (2006) (24)
Scintigraphic detection of acute experimental endocarditis with the technetium-99m labelled glycoprotein IIb/IIIa receptor antagonist DMP444 (2000) (24)
Comparison of three remote radiolabelling methods for long-circulating liposomes. (2015) (24)
Preferential localization of systemically administered radiolabeled interleukin 1alpha in experimental inflammation in mice by binding to the type II receptor. (1997) (23)
Characterization and optimization of image quality as a function of reconstruction algorithms and parameter settings in a Siemens Inveon small-animal PET scanner using the NEMA NU 4-2008 standards (2011) (23)
Radioimmunotherapy of B-cell non-Hodgkin's lymphoma (2001) (23)
A 99Tcm-labelled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbits (2000) (23)
Scintigraphic imaging using 99mTc-labeled PEG liposomes allows early detection of experimental invasive pulmonary aspergillosis in neutropenic rats. (2002) (23)
Software package for integrated data processing for internal dose assessment in nuclear medicine (SPRIND) (2007) (23)
Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin. (2008) (23)
Monitoring hypoxia and vasculature during bevacizumab treatment in a murine colorectal cancer model. (2014) (23)
Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma. (2003) (23)
Evaluating the learning curve for retroperitoneoscopic adrenalectomy in a high-volume center for laparoscopic adrenal surgery (2016) (23)
Radionuclide therapy of cancer with radiolabeled antibodies. (2007) (23)
The uptake mechanisms of inflammation-and infection-localizing agents (1996) (23)
Dissociation of indium from indium-111-labelled diethylene triamine penta-acetic acid conjugated non-specific polyclonal human immunoglobulin G in inflammatory foci (1995) (23)
111In-Cetuximab-F(ab′)2 SPECT and 18F-FDG PET for Prediction and Response Monitoring of Combined-Modality Treatment of Human Head and Neck Carcinomas in a Mouse Model (2015) (23)
Discriminating infection from sterile inflammation: can radiolabelled antibiotics solve the problem? (2005) (23)
Kinetics of 99mTc-labeled interleukin-8 in experimental inflammation and infection. (2003) (22)
Radionuclide and Fluorescence Imaging of Clear Cell Renal Cell Carcinoma Using Dual Labeled Anti-Carbonic Anhydrase IX Antibody G250. (2015) (22)
111In-anti-F4/80-A3-1 antibody: a novel tracer to image macrophages (2015) (22)
In Vivo Characterization of 4 68Ga-Labeled Multimeric RGD Peptides to Image αvβ3 Integrin Expression in 2 Human Tumor Xenograft Mouse Models (2018) (22)
99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection. (2002) (22)
Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargeting. (2005) (22)
The effect of molecular weight on nonspecific accumulation of (99m)T-labeled proteins in inflammatory foci. (2001) (22)
Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount (2014) (22)
Imaging fibroblast activation protein to monitor therapeutic effects of neutralizing interleukin-22 in collagen-induced arthritis (2018) (22)
Radionuclide and Fluorescence Imaging of Clear Cell Renal Cell Carcinoma Using Dual Labeled Anti-Carbonic Anhydrase IX Antibody G250. (2015) (22)
Timing of Adjuvant Radioimmunotherapy after Cytoreductive Surgery in Experimental Peritoneal Carcinomatosis of Colorectal Origin (2007) (21)
Preclinical Evaluation of 68Ga-DOTA-Minigastrin for the Detection of Cholecystokinin-2/Gastrin Receptor-Positive Tumors (2011) (21)
Optimization of Dual-Labeled Antibodies for Targeted Intraoperative Imaging of Tumors (2015) (21)
The kinetics and mechanism of bone morphogenetic protein 2 release from calcium phosphate-based implant-coatings. (2018) (21)
INTERMITTENT ANDROGEN SUPPRESSION IN PATIENTS WITH ADVANCED PROSTATE CANCER: AN UPDATE OF THE TULP SURVIVAL DATA (2008) (21)
Novel antigens characteristic of neuroendocrine malignancies (1991) (21)
Improved imaging of infections by avidin-induced clearance of 99mTc-biotin-PEG liposomes. (2000) (21)
Development of Infection and Inflammation Targeting Compounds (2008) (20)
Monitoring the biological effect of BMP-2 release on bone healing by PET/CT. (2014) (20)
Targeting CD44v6 for fluorescence-guided surgery in head and neck squamous cell carcinoma (2018) (20)
Increased interleukin-1alpha and interleukin-1beta production by macrophages of low-density lipoprotein receptor knock-out mice stimulated with lipopolysaccharide is CD11c/CD18-receptor mediated. (1998) (20)
Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti‐di‐diethylenetriaminepentaacetic acid F(ab′)2 antibody (2010) (20)
Increased Metabolic Activity of Indolent Liver Metastases After Resection of a Primary Colorectal Tumor (2008) (20)
Time-resolved immunofluorometric assay (TR-IFMA) for the detection of the schistosome circulating anodic antigen. (1989) (20)
Scintigraphic Imaging of Inflammatory Processes (2002) (20)
111In-cetuximab-F(ab')2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts. (2013) (20)
Radiolabeled antibodies in renal cell carcinoma (2007) (20)
Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation. (2010) (20)
Final results of a phase I radioimmunotherapy trial using (186)Re-epratuzumab for the treatment of patients with non-Hodgkin's lymphoma. (2003) (19)
Scintigraphic imaging of bacterial and fungal infection in granulocytopenic rats. (1999) (19)
Assessment of volume preservation performed before or after partial nephrectomy accurately predicts postoperative renal function: Results from a prospective multicenter study. (2019) (19)
Non-invasive in vivo determination of viable islet graft volume by 111In-exendin-3 (2017) (19)
99mTc-labeled interleukin-8 for scintigraphic detection of pulmonary infections. (2004) (19)
99mTc-CXCL8 SPECT to Monitor Disease Activity in Inflammatory Bowel Disease (2016) (19)
Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2×Anti-HSG Bispecific Antibody and a (177)Lu-Labeled Peptide. (2014) (19)
Pretargeted ImmunoPET of Prostate Cancer with an Anti-TROP-2 x Anti-HSG Bispecific Antibody in Mice with PC3 Xenografts (2015) (19)
Radiolabeling of liposomes for scintigraphic imaging. (2003) (19)
Components of pain assessment after laparoscopic donor nephrectomy (2014) (18)
Soluble murine IL-1 receptor type I induces release of constitutive IL-1 alpha. (1999) (18)
Current Status of Focal Cryoablation for Small Renal Masses. (2016) (18)
CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models (2019) (18)
In Vitro and In Vivo Characterization of an 18F-AlF-Labeled PSMA Ligand for Imaging of PSMA-Expressing Xenografts (2019) (18)
Can 111In-RGD2 Monitor Response to Therapy in Head and Neck Tumor Xenografts? (2014) (18)
Preventing Radiobleaching of Cyanine Fluorophores Enhances Stability of Nuclear/NIRF Multimodality Imaging Agents (2017) (18)
Spacer Effects on in vivo Properties of DOTA‐Conjugated Dimeric [Tyr3]Octreotate Peptides Synthesized by a “CuI‐Click” and “Sulfo‐Click” Ligation Method (2011) (18)
Intracavitary radioimmunotherapy to treat solid tumors. (2008) (17)
Molecular imaging and carbonic anhydrase IX-targeted radioimmunotherapy in clear cell renal cell carcinoma. (2013) (17)
In-depth evaluation of the cycloaddition--retro-Diels--Alder reaction for in vivo targeting with [(111)In]-DTPA-RGD conjugates. (2009) (17)
Imaging of infection in rabbits with radioiodinated interleukin-1 (alpha and beta), its receptor antagonist and a chemotactic peptide: a comparative study. (1998) (17)
Chronic pain following laparoscopic living‐donor nephrectomy: Prevalence and impact on quality of life (2019) (17)
MRI as a tool to assess surgical margins and pseudocapsule features directly following partial nephrectomy for small renal masses (2018) (17)
Radioimmunotherapy Improves Survival of Rats with Microscopic Liver Metastases of Colorectal Origin (2009) (17)
In vivo expression of interleukin-1 receptors during various experimentally induced inflammatory conditions. (1998) (17)
Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft Models (2018) (17)
Central delivery of iodine-125–labeled cetuximab, etanercept and anakinra after perispinal injection in rats: possible implications for treating Alzheimer’s disease (2015) (16)
Pretargeting of Carcinoembryonic Antigen–Expressing Tumors with a Biologically Produced Bispecific Anticarcinoembryonic Antigen × Anti-Indium–Labeled Diethylenetriaminepentaacetic Acid Antibody (2005) (16)
Graft revascularization is essential for non-invasive monitoring of transplanted islets with radiolabeled exendin (2015) (16)
PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation. (2007) (16)
Optimization of Dual-Labeled Antibodies for Targeted Intraoperative Imaging of Tumors. (2015) (16)
In Vivo Imaging of Antileukemic Drug Asparaginase Reveals a Rapid Macrophage-Mediated Clearance from the Bone Marrow (2017) (16)
Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists. (2006) (16)
Non-glycosylated BMP-2 can induce ectopic bone formation at lower concentrations compared to glycosylated BMP-2. (2012) (16)
SPECT vs. PET monitoring of bone defect healing and biomaterial performance in vivo (2016) (16)
Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas. (1998) (15)
Noninvasive Imaging of Islet Transplants with 111In-Exendin-3 SPECT/CT (2016) (15)
Digitalis-like Compounds Facilitate Non-Medullary Thyroid Cancer Redifferentiation through Intracellular Ca2+, FOS, and Autophagy-Dependent Pathways (2016) (15)
Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice. (1991) (15)
Liposomes for scintigraphic imaging: optimization of in vivo behavior. (1998) (15)
Influence of antibody protein dose on therapeutic efficacy of radioiodinated antibodies in nude mice bearing GW-39 human tumor (2005) (15)
Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC (2015) (15)
Development of 111In-labeled tumor-associated antigen peptides for monitoring dendritic-cell-based vaccination. (2006) (15)
Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging (2016) (15)
Novel Tumor-Targeted, Engineered IL-2 Variant (IL2v)-Based Immunocytokines For Immunotherapy Of Cancer (2013) (14)
Scintigraphic imaging of infectious foci with an 111In-LTB4 antagonist is based on in vivo labeling of granulocytes. (2005) (14)
Adjuvant Radioimmunotherapy Improves Survival of Rats After Resection of Colorectal Liver Metastases (2011) (14)
Construct, content and face validity of the camera handling trainer (CHT): a new E-BLUS training task for 30° laparoscope navigation skills (2016) (14)
Perfluorocarbon/Gold Loading for Noninvasive in Vivo Assessment of Bone Fillers Using 19F Magnetic Resonance Imaging and Computed Tomography (2017) (14)
Imaging of infection and inflammation with an improved 99mTc-labeled LTB4 antagonist. (2005) (14)
Increased Adipocyte Size, Macrophage Infiltration, and Adverse Local Adipokine Profile in Perirenal Fat in Cushing's Syndrome (2017) (14)
Validation of 111In-Exendin SPECT for the Determination of the β-Cell Mass in BioBreeding Diabetes-Prone Rats (2018) (14)
Management of localized and locally advanced renal tumors. A contemporary review of current treatment options. (2013) (14)
Different behaviour of radioiodinated human recombinant interleukin-1 and its receptor antagonist in an animal model of infection (1996) (14)
Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation. (2003) (14)
SPECT of Transplanted Islets of Langerhans by Dopamine 2 Receptor Targeting in a Rat Model. (2016) (13)
Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re. (2003) (13)
Scanning multiple mice in a small-animal PET scanner: Influence on image quality. (2010) (13)
Nuclear medicine imaging and therapy of neuroendocrine tumours (2006) (13)
Is somatostatin receptor scintigraphy suited to detection of acute infectious disease? (1994) (13)
Radionuclide imaging of drug delivery for patient selection in targeted therapy (2014) (13)
Early Response Monitoring with 18F-FDG PET and Cetuximab-F(ab′)2-SPECT After Radiotherapy of Human Head and Neck Squamous Cell Carcinomas in a Mouse Model (2014) (13)
Surgical team composition has a major impact on effectiveness and costs in laparoscopic donor nephrectomy (2014) (13)
Tumour targeting of the anti-ovarian carcinoma x anti-CD3/TCR bispesific monoclonal antibody OC/TR and its parental MOv18 antibody in experimental ovarian cancer. (1995) (13)
Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer (2017) (13)
Preclinical validation of 111In-girentuximab-F(ab')2 as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenografts. (2017) (13)
Evaluation of Tc-99m-labeled glycoprotein IIb/IIIa receptor antagonist DMP444 SPECT in patients with infective endocarditis. (2003) (13)
Tumor-receptor imaging in breast cancer: a tool for patient selection and response monitoring. (2013) (13)
Image quality phantom and parameters for high spatial resolution small-animal SPECT (2011) (13)
Effect of the route of administration on the biodistribution of radioiodinated OV-TL 3 F(ab′)2 in experimental ovarian cancer (1994) (12)
Preclinical imaging in bone tissue engineering. (2014) (12)
Therapy response monitoring of the early effects of a new BRAF inhibitor on melanoma xenograft in mice: evaluation of (18) F-FDG-PET and (18) F-FLT-PET. (2015) (12)
Characterization of Site-Specifically Conjugated Monomethyl Auristatin E– and Duocarmycin-Based Anti-PSMA Antibody–Drug Conjugates for Treatment of PSMA-Expressing Tumors (2017) (12)
Endotoxin tolerance does not limit mild ischemia-reperfusion injury in humans in vivo (2009) (12)
Reply to LTE: Inhibition of Kidney Uptake of Radiolabeled Somatostatin Analogs: Amino Acids or Gelofusine? (2006) (12)
Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor (2005) (12)
Postprostatectomy ultrasound-guided transrectal implantation of gold markers for external beam radiotherapy (2013) (12)
Quantitative Immuno-SPECT Monitoring of Pretargeted Radioimmunotherapy with a Bispecific Antibody in an Intraperitoneal Nude Mouse Model of Human Colon Cancer (2012) (12)
The strength of small: improved targeting of insulin-like growth factor-1 receptor (IGF-1R) with F(ab')₂-R1507 fragments in Ewing sarcomas. (2013) (12)
Multimodality Probes: Amphibian Cars for Molecular Imaging (2008) (12)
Combination therapy using gemcitabine and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin. (2006) (11)
Specific targeting of tumor cells by lyophilisomes functionalized with antibodies. (2014) (11)
Comparison of synchronous bilateral transperitoneal and posterior retroperitoneal laparoscopic adrenalectomy: results of a multicenter study (2020) (11)
Monoclonal antibodies that discriminate between human ovarian carcinomas and benign ovarian tumours. (1990) (11)
Controlled Release of rhBMP-2 Loaded Poly(DL-lactic-co-glycolic Acid)/ Calcium Phosphate Cement Composites In Vivo (2006) (11)
Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity (2020) (11)
The effect of purification of Ga-68-labeled exendin on in vivo distribution (2016) (11)
Radioimmunotherapy prevents local recurrence of colonic cancer in an experimental model (2009) (11)
Monoclonal antibodies against ovarian carcinoma-associated antigens, raised by immunization with cyst fluids. (1989) (11)
Absorption and biodistribution of 111indium-labelled desferrioxamine (111In-DFO) after subcutaneous injection of 111In-DFO liposomes. (1999) (11)
Measuring the pancreatic beta cell mass in vivo with exendin SPECT during hyperglycemia and severe insulitis. (2019) (11)
Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy (2015) (11)
PET of Hypoxia with 89 Zr-Labeled cG250-F(ab9) 2 in Head and Neck Tumors (2010) (11)
Biodistribution and imaging of FDG in rats with LS174T carcinoma xenografts and focal Escherichia coli infection. (2005) (10)
Kinetics and biodistribution in relation to tumour detection with 111 In labelled OV‐TL 3 F(ab,)2 in patients with ovarian cancer (1991) (10)
18F-Labelled exendin to image GLP-1 receptor-expressing tissues: from niche to blockbuster? (2011) (10)
Intratumoral Spatial Distribution of Hypoxia and Angiogenesis Assessed by 18F-FAZA and 125I-Gluco-RGD Autoradiography (2008) (10)
Decreased kidney uptake of technetium-99m-labelled Fab' fragments in ovarian carcinoma bearing nude mice using a cleavable chelator. (1994) (10)
The biological performance of injectable calcium phosphate/PLGA cement in osteoporotic rats (2013) (10)
In Vitro and In Vivo Characterization of Three 68Ga- and 111In-Labeled Peptides for Cholecystokinin Receptor Imaging (2012) (10)
Time-resolved immunofluorometric assay for the ovarian carcinoma-associated antigenic determinant CA 125 in serum. (1987) (10)
Impact of surgical approach and resection technique on the risk of Trifecta Failure after partial nephrectomy for highly complex renal masses. (2021) (10)
Imaging acute appendicitis: an opportunity for nuclear medicine in the surgical emergency room. (2000) (9)
Rosiglitazone reduces ischaemia-reperfusion injury in patients with the metabolic syndrome. (2010) (9)
Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm. (1998) (9)
Imaging of experimental colitis with a radiolabeled leukotriene B4 antagonist. (2004) (9)
Characterization of 111In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors (2018) (9)
Effect of nanotubes and apatite on growth factor release from PLLA scaffolds (2011) (9)
Ex Vivo Assessment of Tumor-Targeting Fluorescent Tracers for Image-Guided Surgery (2020) (9)
Comparison of IgG and F(ab′)2 fragments of bispecific anti-RCC×anti-DTIn-1 antibody for pretargeting purposes (2005) (9)
Technetium-99m labelled hydrazinonicotinamido human non-specific polyclonal immunoglobulin G for detection of infectious foci: a comparison with two other technetium-labelled immunoglobulin preparations (1996) (9)
A 3-step pretargeting strategy to image infection. (2001) (9)
Optimizing Lutetium 177–Anti–Carbonic Anhydrase IX Radioimmunotherapy in an Intraperitoneal Clear Cell Renal Cell Carcinoma Xenograft Model (2014) (9)
Humoral anti‐OV-TL 3 response after the intravenous administration of radiolabelled Fab' or F(ab')2 fragments in ovarian cancer patients (1995) (9)
Antibody therapy in renal cell carcinoma (2008) (8)
Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy (2019) (8)
Lyophilization of TC-99m-Hynic Labeled Peg-Liposomes (2000) (8)
Contribution of normalization to image noise for the Siemens Inveon small-animal PET scanner (2009) (8)
Monitoring 111In-labelled polyisocyanopeptide (PIC) hydrogel wound dressings in full-thickness wounds. (2019) (8)
Combination therapy using the cyclooxygenase-2 inhibitor Parecoxib and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin (2005) (8)
Cetuximab reduces the accumulation of radiolabeled bevacizumab in cancer xenografts without decreasing VEGF expression. (2014) (8)
Progress in gene therapy: seeing is believing. (2001) (8)
Relationship between neutrophil-binding affinity and suitability for infection imaging: comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms. (2004) (8)
Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68Ga]Ga-DOTA-E-[c(RGDfK)]2 PET/CT (2020) (8)
Scintigraphic imaging of P-glycoprotein expression with a radiolabelled antibody (2006) (8)
Erratum re: "Surgical Management of Adrenocortical Carcinoma: Impact of Laparoscopic Approach, Lymphadenectomy, and Surgical Volume on Outcomes-A Systematic Review and Meta-analysis of the Current Literature" [Eur Urol Focus, 2015; 1 (3) 241-250]. (2016) (8)
Improved Quantification of the Beta Cell Mass after Pancreas Visualization with 99mTc-demobesin-4 and Beta Cell Imaging with 111In-exendin-3 in Rodents. (2016) (8)
Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach (2013) (8)
Monoclonal antibody therapy of kidney cancer. (2003) (8)
Percutaneous MR Imaging-Guided Cryoablation of Small Renal Masses in a 3-T Closed-Bore MR Imaging Environment: Initial Experience. (2017) (8)
for Targeted SPECT/CT Imaging of Prostate Cancer (2015) (7)
Hyperthermia and fibrinolytic therapy do not improve the beneficial effect of radioimmunotherapy following cytoreductive surgery in rats with peritoneal carcinomatosis of colorectal origin. (2008) (7)
PO-5: Targeting inflammation with radiolabelled interleukin-1 and other cytokines in various mouse models (1997) (7)
Phase I clinical study of the feasibility of pretargeted radioimmunotherapy (PT-RAIT) in patients with colorectal cancer (CRC): First results (2011) (7)
Atorvastatin does not affect ischaemia-induced phosphatidylserine exposition in humans in-vivo. (2012) (7)
Targeting of biliary cancer with radiolabeled chimeric monoclonal antibody CG250. (2006) (7)
Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/ IL2Rg Mice (2017) (7)
What is the contemporary role of radiofrequency ablation in the management of small renal masses? Are small lesions the radiologist's tumors? (2013) (7)
FIAU: From reporter gene imaging to imaging of bacterial proliferation. (2012) (7)
Tumor Targeting Using Radiolabeled Antibodies for Image-Guided Drug Delivery. (2015) (7)
Optimizing lutetium 177-anti-carbonic anhydrase IX radioimmunotherapy in an intraperitoneal clear cell renal cell carcinoma xenograft model. (2014) (7)
Dynamics of IGF-1R Expression During Endocrine Breast Cancer Treatment (2014) (7)
Determination of the beta-cell mass by SPECT imaging with In-111-DTPA-Exendin-3 in rats (2009) (7)
[18F]FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma (2007) (6)
Effects of attenuation map accuracy on attenuation-corrected micro-SPECT images (2013) (6)
Rapid imaging of experimental infection with technetium-99m-DTPA after anti-DTPA monoclonal antibody priming. (1997) (6)
Enhancing tumor implantation and growth rate of Ramos B-cell lymphoma in nude mice. (2002) (6)
Experimental study of radioimmunotherapy versus chemotherapy for colorectal cancer (2011) (6)
Tissue distribution of 99mTc, 111In and 123I-OV-TL 3 Fab' in ovarian carcinoma bearing nude mice. (1991) (6)
Immunocytochemical detection of ovarian carcinoma cells in serous effusions. (1993) (6)
Epidermal growth factor receptor imaging in human head and neck cancer xenografts (2015) (6)
Two-step targeting of RCC tumors in mice (1998) (6)
Reduction of treatment volume and radiation doses to surrounding tissues with intraprostatic gold markers in prostate cancer radiotherapy. (2011) (6)
Quantitative and longitudinal imaging of intramuscular transplanted islets of Langerhans with SPECT using [ 123I]IBZM (2017) (6)
Detrusor overactivity does not predict bothersome storage symptoms after photoselective vaporization of the prostate with lithium triborate laser. (2014) (6)
Targeted radionuclide therapy of cancer (2009) (6)
Tc-99m-labeled C5a and C5a des Arg74 for infection imaging. (2003) (6)
Scintigraphic detection of pulmonary aspergillosis in rabbits with a radiolabeled leukotriene b4 antagonist. (2004) (6)
Abstract 486: Tumor-targeted, engineered IL-2 variant (IL-2v)-based immunocytokines for the immunotherapy of cancer. (2013) (6)
Long-circulating liposomes for i.v. targeted delivery of glucocorticoids in arthritis. (2002) (6)
Diagnostic and Therapeutic Targeting of Infectious and Inflammatory Diseases Using Sterically Stabilized Liposomes (1998) (6)
Fluorinated amino acids for tumour imaging with positron emission tomography (2002) (6)
Analysis of idiotope structure of ovarian cancer antibodies: recognition of the same epitope by two monoclonal antibodies differing mainly in their heavy chain variable sequences (1994) (5)
Spatial resolution of the Inveon small-animal PET scanner for the entire field of view (2010) (5)
The Performance Improvement (Pi) score: an algorithm to objectively score performance improvement during E-BLUS hands on training (HoT) sessions. An ESUT project. (2018) (5)
Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci. (2005) (5)
Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging (2017) (5)
Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models (2019) (5)
Effect of the positron range on the spatial resolution of a new generation pre-clinical PET-scanner using F-18, Ga-68, Zr-89 and I-124 (2008) (5)
DOUBLE J STENT IS SUPERIOR TO EXTERNALLY DRAINING URETERIC STENT IN ENHANCING RECOVERY AFTER KIDNEY TRANSPLANTATION - a prospective cohort study. (2019) (5)
Angiotensin II Type 1 Receptor Blockade Does Not Enhance Apoptotic Cell Death During Ischemia and Reperfusion in Humans In Vivo (2011) (5)
Multimodal CEA-targeted fluorescence and radioguided cytoreductive surgery for peritoneal metastases of colorectal origin (2022) (5)
Al18F: A New Standard for Radiofluorination (2013) (5)
Adjuvant radioimmunotherapy after radiofrequency ablation of colorectal liver metastases in an experimental model. (2011) (5)
A pretargeted multimodal approach for image-guided resection in a xenograft model of colorectal cancer (2019) (4)
Detection of infection and inflammation with technetium-99m-labeled PEG-liposomes (1999) (4)
Differences in clinical presentation and management between pre- and postsurgical diagnoses of urinary bladder paraganglioma: is there clinical relevance? A systematic review (2021) (4)
Response Monitoring with [18F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases (2016) (4)
Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with 111In-girentuximab (2019) (4)
A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using 68Ga-RGD PET/CT (2020) (4)
Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with 111In-girentuximab (2019) (4)
Upregulation of IGF-1 R Expression during Neoadjuvant Therapy Predicts Poor Outcome in Breast Cancer Patients (2017) (4)
Tissue distribution of technetium 99m indium 111 labelled and iodine 123 ov tl 3 fab in ovarian carcinoma bearing nude mice (1991) (4)
[99mTc]-labelled interleukin-8 as a diagnostic tool compared to [18F]FDG and CT in an experimental porcine osteomyelitis model. (2020) (4)
Novel VHH-Based Tracers with Variable Plasma Half-Lives for Imaging of CAIX-Expressing Hypoxic Tumor Cells (2022) (4)
In vivo Molecular Prediction of Carbonic Anhydrase IX-G250MN Expression on Immunotherapy Outcome in Renal Cancer (2005) (4)
Imaging , Diagnosis , Prognosis Predicting IGF-1 R Therapy Response in Bone Sarcomas : Immuno-SPECT Imaging with Radiolabeled R 1507 (2011) (4)
Kidney protection during peptide receptor radionuclide therapy (PRRT) (2009) (4)
Radiolabeled imaging probes targeting angiogenesis for personalized medicine. (2014) (4)
Impact of Trifecta definition on rates and predictors of "successful" robotic partial nephrectomy for localized renal masses: results from the Surface-Intermediate-Base Margin Score International Consortium. (2022) (4)
Venous thromboembolism in patients with adrenocortical carcinoma after surgery (2020) (4)
Pyruvate‐lactate exchange and glucose uptake in human prostate cancer cell models. A study in xenografts and suspensions by hyperpolarized [1‐13C]pyruvate MRS and [18F]FDG‐PET (2020) (3)
Abstract 2761: Temsirolimus is effective as a single agent and in combination with cisplatin or bevacizumab in preclinical osteosarcoma models. (2013) (3)
SPECT/CT imaging of tumor PD-L1 expression using radiolabeled anti-PD-L1 antibodies (2015) (3)
Volumetric evaluation of CT images of adrenal glands in primary aldosteronism (2021) (3)
Intraoperative dual-modality imaging in clear cell renal cell carcinoma using Indium-111-DOTA-girentuximab-IRDye800CW (2017) (3)
Challenges, hurdles and possible approaches to improve cancer care in developing countries – A short breakdown of the status quo and future perspective (2017) (3)
Biodistribution of 111In‐labelled IgG and IgM in experimental infection (1996) (3)
Labeling method largely affects the imaging potential of interleukin-8. (2002) (3)
493 Decreasing operating times and complication rates after laparoscopic donor nephrectomy by different techniques in highly experienced surgical teams (2013) (3)
421 Targeted dual-modality imaging in renal cell carcinoma: An ex vivo kidney perfusion study (2015) (3)
Can antibody galactosylation be used to improve radioimmunotherapy of induced peritoneal carcinomatosis of colonic origin in the rat? (2009) (3)
Performance Improvement (Pi) score: an algorithm to score Pi objectively during E‐BLUS hands‐on training sessions. A European Association of Urology, Section of Uro‐Technology (ESUT) project (2019) (3)
Pretargeted immunoPET imaging and radioimmunotherapy (RIT) of prostate cancer with an anti-EGP1 x anti-HSG bispecific antibody (bsMAb) (2010) (3)
MR tracking of magnetically-labeled dendritic cells migrating to lymph nodes in melanoma patients: First clinical experience (2005) (3)
Effectiveness of Heated Sterile Water vs ResoClear® for Prevention of Laparoscopic Lens Fogging in a Randomized Comparative Trial. (2018) (3)
Pharmacokinetics, biodistribution and dosimetry of anti-NCAM monoclonal antibody RNL-1 and its fragments in experimental lung cancer (1996) (2)
Radioimmunotherapy with Lutetium-177 labeled monoclonal antibody cG250 in patients with advanced renal cell carcinoma (2008) (2)
Biodistribution, Binding and Internalisation of Monoclonal Antibodies to Human Ovarian Carcinoma Cells (1990) (2)
12 Phase II study of lutetium-177-labeled anti carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma (2015) (2)
Pretargeted immunoPET for imaging human colonic cancer in a mouse model (2010) (2)
Specific antibody uptake in tuberculosis? (1993) (2)
Tracers to monitor the response to chemotherapy: in vitro screening of four radiopharmaceuticals. (2004) (2)
Zirconium-89-girentuximab PET/CT imaging in renal cell carcinoma: First in man results (2016) (2)
18F-2-Deoxy-2-Fluoro-D-Glucose Positron Emission Tomography, Computed Tomography, and Magnetic Resonance Imaging for the Detection of Experimental Colorectal Liver Metastases (2012) (2)
FDG-PET, CT and MRI for the detection of experimental colorectal liver metastases: An exploratory study (2011) (2)
259 INTERIM ANALYSIS OF A PHASE I RADIOIMMUNOTHERAPY STUDY IN ADVANCED RENAL CELL CARCINOMA PATIENTS USING LUTETIUM-177 LABELED MONOCLONAL ANTIBODY CG250 (2009) (2)
Y-86 and In-111 labeled alpha(V beta 3) binding peptides: A comparative dosimetric study in dogs. (2001) (2)
Identification of sex-linked antigens ofSchistosoma mansoni by immunoelectrophoresis and immunoblotting (1986) (2)
269 OPTICAL IMAGING OF RENAL CELL CARCINOMA USING THE ANTI-CAIX MONOCLONAL ANTIBODY CG250 (2011) (2)
Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma: Biological and Clinical Studies (2009) (2)
Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan (2017) (2)
862 RADIOIMMUNOTHERAPY OF ADVANCED RENAL CELL CARCINOMA PATIENTS WITH LUTETIUM-177 LABELED MONOCLONAL ANTIBODY CG250 (2007) (2)
Development of ELISAs for quantification of HMFG1-specific human anti-mouse IgG and IgM antibodies. (2007) (2)
Preclinical evaluation of technetium 99m-labeled P1827DS for infection imaging and comparison with technetium 99m IL-8. (2007) (2)
Imaging carbonic anhydrase IX as a method for monitoring hypoxia-related radioresistance in preclinical head and neck cancer models (2021) (2)
29 ORAL Radioimmunotherapy is an effective adjuvant therapy to cytoreductive surgery for peritoneal carcinomatosis of Colonic Origin (2006) (2)
In vivo visualization of transplanted islets in rats by SPECT with In-111-Exendin-3 (2011) (2)
Abstract PR8: Novel tumor-targeted, engineered IL-2 variant (IL-2v)-based immunocytokines for immunotherapy of cancer. (2013) (2)
336 Sorafenib decreases Indium-111-girentuximab tumor uptake in clear cell renal cell carcinoma patients (2013) (2)
13th Meeting of the International Research Group on Immunoscintigraphy and Immunotherapy (IRIST). 7-8 May 1999, Göttingen, Germany. (1999) (2)
Evaluation of CCK2 receptor binding ligands: the inheritance of Thomas Behr (2011) (2)
980 Optimization of Lutetium-177-G250 radioimmunotherapy in an intraperitoneal clear cell renal cell carcinoma xenograft model (2013) (2)
12 Phase II study of lutetium-177-labeled anti carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma (2015) (2)
Perioperative imaging techniques and immunohistochemistry to investigate the feasibility of laparoscopic partial adrenalectomy in primary aldosteronism (2018) (2)
Kidney tumor diffusion-weighted magnetic resonance imaging derived ADC histogram parameters combined with patient characteristics and tumor volume to discriminate oncocytoma from renal cell carcinoma. (2021) (2)
A pedunculated aldosterone‐producing adenoma drained by an extra vein causing puzzling results of adrenal vein sampling (2018) (2)
Changes of the CYP11B2 Expressing Zona Glomerulosa in Human Adrenals From Birth to 40 Years of Age (2022) (2)
Clinical performance in ERN eUROGEN for penile, testicular, adrenal and soft tissue cancers. (2021) (2)
336 Sorafenib decreases Indium-111-girentuximab tumor uptake in clear cell renal cell carcinoma patients (2013) (2)
OP-5. Imaging focal infection in granulocytopaenic rats: Comparison of 67Ga and three 99Tcm-labelled agents (1997) (1)
Sterically Stabilized Liposomes to Image Infection and Inflammation (1998) (1)
In vivo imaging of therapy-induced anti-cancer immune responses in humans (2012) (1)
SPECT to monitor disease activity in inflammatory bowel disease (2015) (1)
Tumor targeting with radiolabeled alfavbeta3 integrin binding RGD peptides in a nude mouse model (2001) (1)
Bone Regenerative Properties of Injectable Calcium Phosphate/PLGA Cement in an Alveolar Bone Defect (2012) (1)
Effect of multiple injections on pharmacokinetics and biodistribution of sterically stabilized liposomes (1998) (1)
JOINT TARGETING OF GLUCOCORTICOIDS WITH LONG-CIRCULATING LIPOSOMES INDUCES COMPLETE REMISSION OF EXPERIMENTAL ARTHRITIS (2003) (1)
A Fully Automated Procedure for the GMP-Synthesis of 68Ga-NODAGA-Exendin-4 Using a Cationic Purification Method (2015) (1)
Additional information on “Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for 89Zr-immunoPET” (2019) (1)
Phase I clinical study of pretargeted radioimmunotherapy (PRIT) in patients with colorectal cancer (CRC): An update (2012) (1)
Tumor hypoxia as a mechanism of resistance to bevacizumab in a murine model. (2012) (1)
Rebuttal from Authors re: J. Stephen Jones. Ten Misconceptions Regarding Cryotherapy for Prostate Cancer. Eur Urol 2009;55:52–5 (2009) (1)
PP 46 In vivo imaging of modulation of IGF-1R expression in breast cancer models (2011) (1)
PS2 - 7. Non-invasive determination of the beta cell mass by SPECT with 111In-exendin in a rat model for spontaneous type 1 diabetes (2012) (1)
Targeting human prostate cancer xenografts with In-111-labeled D2B IgG, F(ab ')2 and Fab fragments in nude mice (2012) (1)
421 IMMUNOPET IMAGING OF RENAL CELL CARCINOMA WITH 1241-AND 89ZR-LABELED ANTI-CAIX MONOCLONAL ANTIBODY CG250 (2010) (1)
PS18 - 2. Quantification of the beta cell mass based on 111In-Exendin imaging in patients with type 1 diabetes and healthy controls (2013) (1)
Advances in Brief Effective Migration of Antigen-pulsed Dendritic Cells to Lymph Nodes in Melanoma Patients Is Determined by Their Maturation State 1 , 2 (2002) (1)
[PP.27.07] QUALITY OF LIFE IN PRIMARY ALDOSTERONISM IMPROVES MORE AFTER ADRENALECTOMY THAN AFTER MEDICAL THERAPY (2017) (1)
sCCK8 Analogues for Targeting CCK2-Receptor Positive Tumors: Synthesis and Evaluation (2018) (1)
Radiolabeled interleukin-8: Scintigraphic imaging of infection and sterile inflammation within a few hours after injection (1998) (1)
Use of Radiolabeled Liposomes for Imaging of Infection and Inflammation (2008) (1)
Gelatin-based plasma expander effectively reduces renal uptake of In-111-labeled peptides (2006) (1)
Absorption and biodistribution of indium-labelled (1)
The learning curve of posterior retroperitoneoscopic adrenalectomy: a review of literature (2021) (1)
Oral Presentations—Abstracts (2003) (1)
Tumor targeting with radiolabeled integrin alpha(v beta 3) binding RGD peptides in a nude mouse tumor model. (2001) (1)
Adrenal vein sampling vs. CT scan to determine treatment in primary aldosteronism: An outcome-based randomised diagnostic trial (2017) (1)
Patterns and predictors of resection techniques during partial nephrectomy: Results of a multicenter prospective study from the Surface-Intermediate-Base (SIB) margin score international consortium (IDEAL Phase 2B) (2018) (1)
Kidney Weight in Living and Postmortal Kidney Donation. (2016) (1)
Percutaneous Nephrolithotomy with intraoperative CT scanning improves stone-free rate. (2020) (1)
In vivo visualisation of platelet involvement in infective endocarditis by targeting the glycoprotein IIb/IIIa receptor (2000) (1)
213Bi-labeled PSMA-targeting agents for alpha radionuclide therapy of prostate cancer (2016) (1)
30 ORAL Radioimmunotherapy as adjuvant treatment of peritoneal carcinomatosis of colonic origin is at least as effective as HIPEC (2006) (1)
Imaging of inflamed joints in patients with active rheumatoid arthritis with radiolabeled interleukin-1 receptor antagonist. Initial results (1998) (1)
Gastrointestinal tumors, colorectal (2012) (1)
First equine study of Tc-99m-labeled IgG, PEG-liposomes and leukocytes in experimentally induced focal soft tissue infection in horses (2011) (1)
CXCR4-directed [68Ga]Ga-PentixaFor PET/CT versus adrenal vein sampling performance: a study protocol for a randomised two-step controlled diagnoStic Trial Ultimately comparing hypertenSion outcome in primary aldosteronism (CASTUS) (2022) (1)
Chronic postsurgical pain after minimally invasive adrenalectomy: prevalence and impact on quality of life (2021) (1)
107 Comparison of 18F-MISO autoradiography with immunohistochemistry after modification of hypoxia in human glioma and squamous cell xenografts (2006) (1)
Targeting of Metastatic Renal Cell Carcinoma with the Chimeric Monoclonal Antibody G250 Labeled with 131I or 111In (2003) (1)
Multimodal anti-PSMA ligands for intra-operative tumor detection and targeted photodynamic therapy of PSMA-expressing tumors (2019) (1)
106 Characterization of human squamous cell head and neck carcinoma xenografts using 18F-FLT and 18F-MISO autoradiography and immunohistochemistry (2006) (1)
Correspondence article to “Evaluating the learning curve for posterior retroperitoneoscopic adrenalectomy” (2018) (1)
The Therapeutic Protein Asparaginase Is Efficiently Cleared By Bone Barrow and Spleen Resident Macrophages (2014) (1)
Development and application of monoclonal antibodies against ovarian cancer (1990) (1)
Peptides and monoclonal antibodies in oncology: an introduction. (2003) (1)
Partial Adrenalectomy Carries a Considerable Risk of Incomplete Cure in Primary Aldosteronism. (2021) (1)
Tc-99m-labeled Leukotriene-B4 (LTB4) receptor antagonist RP517 for scintigraphic imaging of infection (2000) (1)
The uptake mechanisms of infection and inflammation imaging agents (2010) (1)
Lesion detection by [Zr]Zr-DFO-girentuximab and [F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma (2020) (1)
Biodistribution of In-111-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice bearing human prostate cancer xenografts (2012) (1)
OP0075 Sensitive Spect/CT Imaging of Synovial Fap Expression after Anti-IL-22 Treatment in Experimental Arthritis (2016) (1)
Noninvasive determination of the beta cell mass in rats by SPECT with 111In-DTPA-Exendin-3 (2011) (1)
Can we predict prostate size by scoring baldness? The relationship of androgenic alopecia and lower urinary tract symptoms (2019) (1)
Predictors of Positive Surgical Margins after Robot-Assisted Partial Nephrectomy for Localized Renal Tumors: Insights from a Large Multicenter International Prospective Observational Project (The Surface-Intermediate-Base Margin Score Consortium) (2019) (1)
Scintigraphic detection of infective endocarditis (IE) with Tc-99m-DMP444 (2000) (1)
Radiolabeled FIAU can discriminate between bacterial infection and sterile inflammation (2007) (1)
Abstract 5267: The Annexin A5 Homodimer Diannexin Protects Against Ischemia Reperfusion Injury Through Phosphatidylserine Binding (2009) (1)
Ex vivo perfusion of tumorous kidneys with a dual-modality imaging probe (2015) (1)
Phase II study of Lutetium-177-labeled anti-Carbonic Anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma. (2015) (1)
Correction to: Differences in clinical presentation and management between pre- and postsurgical diagnoses of urinary bladder paraganglioma: is there clinical relevance? A systematic review (2021) (1)
Pretargeted immunoPET imaging of CEA-expressing tumors using a Ga-68 labeled peptide (2008) (1)
Scintigraphic imaging of VEGF-A expression with radiolabeled anti-VEGF monoclonal antibody (2007) (1)
Ex vivo perfusion of tumorous kidneys with a dual-modality imaging probe (2015) (1)
ImmunoPET and immunoSPECT imaging of IGF-1R expression with radiolabeled R1507 (2010) (1)
Radioimmunotherapy prevents local recurrence of colon cancer in rats (2009) (1)
Pretargeted radioimmunotherapy of non-Hodgkin's lymphoma: best of both worlds? (2000) (1)
Sorafenib decreases Indium-111-girentuximab tumor uptake in clear cell renal cell carcinoma patients (2012) (1)
Correlation of 18F-FLT and 18F-FMISO autoradiography with immunohistochemistry in a series of human squamous cell head and neck carcinoma xenografts (2006) (1)
Immunotargeting of human small cell lung cancer xenografts in athymic mice using a monoclonal antibody (RNL-1) against a neuroendocrine-related antigen. (1991) (1)
Review Intracavitary Radioimmunotherapy to Treat Solid Tumors (2017) (0)
Abstract 5283: MicroSPECT imaging of IGF1R expression with radiolabeled R1507 in osteosarcoma models (2011) (0)
RGD peptides labeled with Y-86 and In-111: A comparative dosimetric study in dogs (2001) (0)
Targeted dual-modality imaging with Indium-111-DTPA-labetuzumab-IRDye800CW to detect pulmonary metastases in a CEA-expressing tumor model. (2016) (0)
PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status (2017) (0)
Abstract 866: Cetuximab treatment reduces VEGF expression and targeting of radiolabeled bevacizumab in breast cancer xenografts. (2013) (0)
Abstract A32: Pretargeted immunoPET of CEA-expressing in intraperitoneal human colonic tumor xenografts in nude mice (2010) (0)
389 Dual modality imaging of clear cell renal cell carcinoma using dual-label anti-Carbonic Anhydrase IX antibody 111Indium-G250-IRDye800CW (2014) (0)
Scintigraphic imaging of angiogenesis. (2008) (0)
OC-0152 IMAGING OF EGFR WITH USPECT IN HEAD AND NECK CANCER XENOGRAFTS WITH 111-IN-LABELED CETUXIMAB-F(ABÍ)2 (2012) (0)
Diagnosis and Management of Urinary Bladder Paragangliomas: A Retrospective International Multicenter Study (2022) (0)
In-111-DOTA-E-[c(RGDfK)](2) for specific in vivo imaging of angiogenesis (2013) (0)
Megalin is essential for the kidney uptake of In-111-labeled peptides: Studies in megalin-deficient mice (2010) (0)
In vitro and in vivo evaluation of novel 89Zr chelators (2019) (0)
111In-anti-F4/80 for in vivo tracking of tumor associated macrophages (2014) (0)
Interleukin-8 Tc-Labeled 99 mSpecific and Rapid Scintigraphic Detection of Infection with (2000) (0)
SP-0537 TRANSLATIONAL STUDIES ON PRETARGETED RADIOIMMUNOTHERAPY OF COLORECTAL CANCER (2012) (0)
Radionuclide and fluorescence imaging of renal cell carcinoma using dual-label anti-Carbonic Anhydrase IX antibody G250 (2014) (0)
Abstract B077: Non-invasive imaging of the PD-1/PD-L1 pathway in syngeneic murine tumor models (2016) (0)
Targeting GRPR-expressing tumors with an 18F-labeled bombesin analog (2011) (0)
Radioimmunoscintigraphy of colorectal cancer using a two-step pre-targeting method (2008) (0)
Fast optimisation of pet tracer synthesis using automated microreactor technology (2011) (0)
Rosuvastatin increases extracellular adenosine in humans in vivo: A New perspective on cardiovascular protection (2008) (0)
Reduced kidney uptake of technetium-99M-labelled FAB fragments in an animal model using a cleavable chelator (1993) (0)
Receptor occupancy constrains the radionuclide specific activity needed for tumour curability with radionuclide therapy more than the range of the beta-particles (2012) (0)
111In-exendin SPECT imaging suggests presence of residual beta cells in patients with longstanding type 1 diabetes (2021) (0)
Impact of resection techniques on perioperative and early functional outcomes after partial nephrectomy for localized renal masses: Results from a prospective, multicentre study (SIB Project) (2019) (0)
OC-0267 Imaging the effect of Atovaquone on the hypoxia-related marker CAIX in head and neck cancer models (2019) (0)
Pretargeted immunoPET for imaging colorectal cancer in a mouse model (2009) (0)
Re: Selective in vitro labeling of white blood cells using 99mTc-labeled liposomes. (2002) (0)
PET imaging of {alpha}v{beta}3 expression in tumors with 68Ga-labeled mono-, di- and tetrameric RGD peptides (2010) (0)
Radiolabeled-DOTA-Exendin-3, a new agent for the detection of insulinomas with PET or SPECT (2009) (0)
localization a nd a ccelerates engraftment o f b one marrow t ransplants (1995) (0)
S1212 Scintigraphic Identification of Pancolitis and Distal Ileitis Using 99mTC-Labeled Interleukin-8 in Inflammatory Bowel Disease (2008) (0)
Abstract P5-01-01:In VivoImaging of Modulation of IGF-1R Expression in a Mouse Model of Estrogen-Sensitive Breast Cancer: (2010) (0)
PSMA I&T for radionuclide imaging and therapy of prostate cancer: preclinical implications of blocking renal uptake with 2-PMPA (2016) (0)
Indication for several different mechanisms of kidney retention of radiolabeled minigastrin analogues (2013) (0)
The higher interleukin-1 production by LPS-stimulated macrophages of LDL-receptor knock-out mice is a CD11c/CD18-mediated phenomenon (1997) (0)
Scintigraphic detection of experimental endocarditis with the Tc-99m labeled GP IIa/IIIb receptor antagonist DMP444 (1998) (0)
A multiprobe approach to monitoring therapy response in rheumatoid arthritis (2015) (0)
Radioimmunotherapy with Lu-177 labeled anti-CAIX monoclonal antibody in advanced renal cell carcinoma (2011) (0)
Development and Characterization of Anti-Renal Cell Carcinoma x Antichelate Bispecific Monoclonal Antibodies for Two-Phase Targeting of Renal Cell Carcinoma1 (2017) (0)
PET 18F-FDG and SPECT 111In-cetuximab-F(ab')2 for early response monitoring after radiotherapy in HNSCC xenografts (2014) (0)
Correlation of Segmented Metabolic Tumor Volume with Outcome - Letter (2010) (0)
Preclinical studies of SPECT and PET tracers for NET. (2014) (0)
The role of megalin in the renal uptake of radiolabeled peptides (2009) (0)
SP-2. Infection imaging with interleukin-1, its receptor antagonist and a chemotactic peptide: Two animal infection models (1997) (0)
The Value of Multiparametric MRI for Assessment of Inferior Vena Cava Wall Invasion by Renal Cell Carcinoma Thrombus: A Prospective Feasibility Study (2019) (0)
Toward standardized reporting of resection strategies and resection techniques for partial nephrectomy: Insights from a multicenter prospective study within the Surface-Intermediate-Base (SIB) margin score international consortium (2018) (0)
Scintigraphic imaging to noninvasively determine VEGF expression in tumors (2007) (0)
Intraoperative dual-modality imaging in clear cell renal cell carcinoma (2022) (0)
Development and validation of a new nomogram for predicting surgical outcome in posterior retroperitoneoscopic adrenalectomy based on preoperative patient characteristics (2021) (0)
List of Referees, 2009 (2010) (0)
Targeting CD44v6 for fluorescence-guided surgery in head and neck squamous cell carcinoma (2018) (0)
Bevacizumab Beyond Progression: How to Monitor Treatment Efficacy? Results of a Functional Imaging Study in Murine Colorectal Cancer (2012) (0)
' s response to reviews Title : Tubular reabsorption and local production govern urine hepcidin-25 excretion (2012) (0)
897Impact of 3, 6 and 9 months neo-adjuvant hormonal treatment on target volume and rectal toxicity in prostate conformal radiotherapy (2005) (0)
Robotic vs. open partial nephrectomy for highly complex renal masses: Results from a multicenter prospective observational study (The SIB International Consortium) (2020) (0)
EFFECT OF SORAFENIB (NEXAVAR®) ON IMAGING OF CLEAR CELL RENAL CELL CARCINOMA USING 111-INDIUM LABELLED BEVACIZUMAB (AVASTIN®) (2008) (0)
Preclinical and Clinical Evidence for Disappearance of Long-Circulating Characteristics of Polyethylene Glycol Liposomes at Low Lipid Dose 1 (2000) (0)
Underestimation of absorbed dose to kidney. (2003) (0)
Coronary heart disease Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34 C > T variant of the AMPD 1 gene (2017) (0)
Adjuvant radioimmunotherapy after resection or RFA of experimental colorectal liver metastases (2010) (0)
Synthesis and characterization of new radiolabeled CCK8 analogues for targeting CCK2 receptor expressing tumors (2009) (0)
Erratum to: Quality of Recovery After Low-Pressure Laparoscopic Donor Nephrectomy Facilitated by Deep Neuromuscular Blockade: A Randomized Controlled Study (2017) (0)
Kidney uptake of radiopeptides occurs via two different mechanisms (2007) (0)
Adjuvant radioimmunotherapy compared to adjuvant chemotherapy in experimental local-regional recurrences of colon cancer (2010) (0)
Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC). (2018) (0)
A simplified approach for F-18 radiolabeling of biomarker-binding peptides for PET imaging of cancer as part of a theranostic approach (2013) (0)
Peptides in a Nude Mouse Model Integrin Binding 3 β v α Tumor Targeting with Radiolabeled Updated (2002) (0)
62. Cytokine production by mononuclear cells of patients with familial hypercholesterolemia (1997) (0)
845 Surgical team composition has a major impact on effectiveness and costs in laparoscopic donor nephrectomy (2015) (0)
MC13-0036 Dynamics of IGF-1R expression during endocrine breast cancer treatment (2013) (0)
Radionuclide and fluorescence imaging of renal cell carcinoma using dual-label anti-Carbonic Anhydrase IX antibody G250 (2014) (0)
420 THE VALUE OF THE BOSNIAK CLASSIFICATION FOR PATHOLOGY OUTCOME IN LAPAROSCOPIC PARTIAL NEFRECTOMY (2010) (0)
pheochromocytoma and paraganglioma from physiological adrenal uptake and its correlation with genotype-dependent expression of catecholamine transporters (2015) (0)
Reply by Authors. (2019) (0)
Non-invasive determination of the beta cell mass by SPECT with In-111-DTPA-exendin-3 in a rat model for spontaneous type 1 diabetes (2012) (0)
292 Radio immunotherapy using 1311-CG250 in patients with metastasized renal cell carcinoma with two consecutive treatments at the maximum tolerated dose (2004) (0)
The effect of bevacizumab on targeting of anti-epidermal growth factor receptor and anti-insulin-like growth factor 1 receptor antibodies. (2012) (0)
Chronic pain and localized hypoesthesia following minimally invasive adrenalectomy: Prevalence and impact on quality of life (2021) (0)
PET/CT-guided early response prediction and optimization of combined modality treatment with radiotherapy and EGFR-inhibition (2010) (0)
Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study (2014) (0)
Effect of sorafenib on imaging of clear cell renal cell carcinoma using 111-Indium labeled bevacizumab (2008) (0)
Non-invasive in vivo determination of viable islet graft volume by 111In-exendin-3 (2017) (0)
Intraoperative MRI-derived volumetric ablation margins and initial correlation with local outcome after MRI-guided cryoablation of renal tumors (2023) (0)
PET/CT with 89Zr-girentuximab can aid in diagnostic dilemmas of clear cell renal cell carcinoma suspicion (2018) (0)
Developments in prostate cancer treatment : improving complication rates (2012) (0)
C174 Who can expect bothersome storage symptoms after photoselective vaporization of the prostate (2013) (0)
Development and characterization of a triple-modality anti-PSMA targeting agent for immuno-SPECT/CT, near-infrared fluorescence imaging and targeted photodynamic therapy of PSMA-expressing tumors (2016) (0)
Imaging of experimental prostate cancer with pretargeted immunoPET and FDG-PET (2012) (0)
PD07-02 STRUCTURAL CHANGES IN THE ZONA GLOMERULOSA IN HUMAN ADRENALS UNDER THE AGE OF 40 (2021) (0)
Surgical and perioperative outcomes after robotic tumor enucleation vs non-enucleative techniques for localized renal masses: Results of a multicenter prospective study from the surface-intermediate-base (SIB) margin score international consortium (2018) (0)
New perioperative imaging techniques, immunohistochemistry and genetic analysis to investigate the suitability of laparoscopic partial adrenalectomy in primary aldosteronism (2019) (0)
Lipopolysaccharide binds and stimulates mononuclear cells before neutralization by circulating lipoproteins can occur (1997) (0)
Characterization of an In-111-labeled anti-PSMA antibody-photosensitizer conjugate for targeted photodynamic therapy of PSMA-expressing tumors (2017) (0)
Multimodal fluorescence-guided surgery of colorectal peritoneal metastases, a phase I/II clinical trial. (2020) (0)
CXCR4-directed Ga-68-PentixaFor PET/CT as a novel diagnostic modality in primary aldosteronism (2023) (0)
QualityofLife inPrimaryAldosteronism : AComparative Effectiveness Study of Adrenalectomy and Medical Treatment (2017) (0)
Targeting of tumor-bound integrin αvβ3 by 111In and 99mTc-labeled peptides RP686 and RP593 (2000) (0)
MRI-guided percutaneous cryoablation of small renal tumors: 3D treatment margin assessment and correlation with local outcome (2021) (0)
Structural changes in the zona glomerulosa of normal aging adrenals (2019) (0)
Clinical Studies Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Speci fi c T-Cell Responses in Melanoma Patients (2013) (0)
D Fferent Behaviour of Radioiodinated Human Recombinant Irterieukin-1 and Its Receptor Antagonist in an Animal Model 0 Infection (2017) (0)
CHANGES OF THE ZONA GLOMERULOSA IN HUMAN ADRENALS FROM BIRTH TO 40 YEARS OF AGE (2022) (0)
Predicting surgical outcome in posterior retroperitoneoscopic adrenalectomy with the aid of a preoperative nomogram (2022) (0)
Robot-assisted posterior retroperitoneal adrenalectomy: A step-by-step procedure (2019) (0)
PD07-07 PREDICTING SURGICAL OUTCOME IN POSTERIOR RETROPERITONEOSCOPIC ADRENALECTOMY BASED ON PREOPERATIVE PATIENT CHARACTERISTICS (2021) (0)
Bevacizumab treatment reduces targeting of anti-epidermal growth factor receptor and anti-insulin-like growth factor 1 receptor antibodies (2012) (0)
Early follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with ¹¹¹In-girentuximab (2020) (0)
A new and rapid method of labeling peptides with F-18 (2010) (0)
Diagnostic utility and pharmacokinetics of PEG-liposomes (1999) (0)
Reply by Authors - Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses (2020) (0)
Imaging experimental intra-abdominal abscesses with Tc-99m-PEG-liposomes and Tc-99m-HYNIC-lgG (1998) (0)
Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer (2022) (0)
MRI for assessment of inferior vena cava wall invasion by renal cell carcinoma with vena cava thrombi (2018) (0)
Predictors of positive surgical margins after partial nephrectomy for localized renal masses: Results of a prospective multicentre study (Surface-Intermediate-Base Project) (2019) (0)
Fast and facile purification of 68Ga-labeled compounds using solid-phase extraction (2011) (0)
Abstract 1755: Pretargeted radioimmunotherapy of an anti-CEA bispecific antibody and177Lu-labeled peptide: a phase I study in patients with advanced colorectal cancer (2012) (0)
Identifying changes in the zona glomerulosa of adrenals in patients below the age of 40 years (2021) (0)
Feasibility of cone-beam CT-guided percutaneous needle positioning with an optical navigation system percutaneous nephrolithotomy: A pilot study (2023) (0)
Characterization of 111In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors (2018) (0)
1456PTHE ROLE OF AXL IN EWING SARCOMA. (2014) (0)
TREATMENT OF PATIENTS WITH HORMONE-REFRACTORY PROSTATE CANCER WITH MITOXANTRONE (2006) (0)
DEVELOPMENT AND CHARACTERIZATION OF ANTI-RCC x ANTI-DTPA BISPECIFIC MONOCLONAL ANTIBODIES FOR TWO-PHASE TARGETING OF RENAL CELL CARCINOMA (1994) (0)
Monitoring therapy response in rheumatoid arthritis: a multiprobe approach. (2015) (0)
Cathepsin B Mediated Lysosomal Degradation in Macrophages Controls the Pharmacokinetics of the Therapeutic Protein Asparaginase (2015) (0)
Early follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with ¹¹¹In-girentuximab (2020) (0)
720 RADIOIMMUNOTHERAPY USING LUTETIUM-177 LABELLED MONOCLONAL ANTIBODY CG250 STABILISES PREVIOUSLY PROGRESSIVE ADVANCED RENAL CELL CARCINOMA (2011) (0)
First clinical experience with technetium-99m labeled PEG-liposomes for the detection of infection and inflammation (1998) (0)
1081 The effect of sorafenib on Indium-111 labeled bevacizumab uptake in patients with clear cell renal cell carcinoma (ccRCC) (2009) (0)
Imaging of epidermal growth factor receptor expression in head and neck cancer xenografts with ultra high resolution single-photon emission computed tomography (USPECT) with 111In-labeled Cetuximab-F(ab')2 (2012) (0)
Monitoring Lutetium-177-anti-CAIX radioimmunotherapy with In-111-anti-CAIX SPECT in an intraperitoneal clear cell renal cell carcinoma xenograft model (2013) (0)
Antibody-based radiopharmaceuticals : new diagnostic approaches (2010) (0)
Response Monitoring with [ 18 F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases (2016) (0)
Pretargeted radioimmunotherapy of prostate cancer with an anti-TROP2 x anti-HSG bispecific antibody (2012) (0)
Bimodal prostate specific membrane antigen ligands for intra-operative tumor detection and photodynamic therapy of prostate cancer (2019) (0)
928 Targeting CAIX: Indium-111 labeled cG250 as a diagnostic tool for renal masses and lesions suspected for metastasis of clear cell renal cell carcinoma (2012) (0)
Monitoring growth of human ovarian carcinoma with a time resolved immunofluorometric assay for ca 125 (1987) (0)
Zr-DFO-girentuximab and [ 18 F ] FDG-PET / CT in patients with newly diagnosed metastatic renal cell carcinoma (2019) (0)
ZonMw ETH project 435004504 - Dataset of MIA rat osteoarthritis model treated with testosteron-aledronate microspheres (2019) (0)
Response Monitoring with [F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases (2020) (0)
19. New developments for scintigraphic imaging of infection: Liposomes, interleukins and peptides (1999) (0)
192 Combination therapy with sunitinib and 177-Lu-girentuximab in RCC (2014) (0)
563 SORAFENIB REDUCES UPTAKE OF 111-INDIUM LABELED BEVACIZUMAB IN CLEAR CELL RENAL CELL CARCINOMA (2010) (0)
20P Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma (2018) (0)
Development of ELISAs for quantification of HMFG1-specific human anti-mouse IgG and IgM antibodies. (2007) (0)
In vivo imaging of vascular integrin avb3 expression (2013) (0)
Quantitative imaging of intramuscular transplanted islets of Langerhans with SPECT by dopamine 2 receptor targeting (2015) (0)
Inhibition of renal uptake of radiolabeled peptides using fragments of albumin (2008) (0)
Pretargeted immuno-PET imaging of prostate cancer (2010) (0)
Carbonic Anhydrase IX and Monoclonal Antibody G250: Relevance as a Clinical and Biologic Target in Renal Cell Carcinoma (2015) (0)
10 oral: PET-Imaging of Hypoxia Using 89ZR-Labeled CG250-F(AB’)2 (2010) (0)
931 Novel nanobody targeting prostate-specific membrane antigen: A promising tracer for imaging of prostate cancer (2015) (0)
2. Rapid and specific detection of inflammation with 99mTc labelled, hynic derivatized IL-8 (2001) (0)
MACROPHAGE TARGETING IN EXPERIMENTAL ARTHRITIS. AUTHORS'S REPLIES (1996) (0)
In memoriam: Marion Hendriks-de Jong (2021) (0)
PET and SPECT imaging of gastrin receptor-expessing tumors with CCK receptor-binding peptides (2011) (0)
02.04 Sensitive spect/ct imaging of synovial fap expression after anti-il-22 treatment in experimental arthritis (2017) (0)
PET and SPECT imaging with a CCK2 receptor-binding peptide comparing various chelators and radionuclides (2013) (0)
Development of a Ga-68-labelled gastrin-based PET tracer for the detection of CCK2/gastrin receptor positive neuroendocrine tumors (2009) (0)
SPECT imaging of transplanted islets: Role of microvasculature in in-vivo delivery of radio-tracers for monitoring of islets survival (2015) (0)
Pretargeted radioimmunotherapy (PT-RAIT) of CEA-expressing tumors in nude mice with subcutaneous and intraperitoneal human tumor xenografts (2010) (0)
Abstract 5282: Pretargeted immunoPET for imaging human colonic cancer in a mouse model (2011) (0)
PD-0449: ImmunoSPECT with 111In-cetuximab-F(abí)2 to predict treatment response in HNSCC xenografts (2013) (0)
PO-0965: Imaging of the hypoxia related marker Carbonic Anhydrase IX in human head and neck cancer xenografts (2017) (0)
Release of Constitutive IL-1 Soluble Murine IL-1 Receptor Type I Induces (1999) (0)
Monoclonal Antibody Girentuximab Carbonic Anhydrase IX − Optical Imaging of Renal Cell Carcinoma with Anti (2014) (0)
Pretargeted PET imaging and radioimmunotherapy of colorectal cancer (2008) (0)
Radionuclide therapy of tumors using alpha-v-beta3 integrin targeting peptides (2002) (0)
Macrophage targeting in experimental arthritis (1996) (0)
Immunoscintigraphy and biodistribution of three 99mTc-G250 mAb preparations in nude mice with SC RCC tumors (1998) (0)
PET/CT with 89Zr-girentuximab can aid in diagnostic dilemmas of clear cell renal cell carcinoma suspicion (2018) (0)
HNSCC Tumor Xenograft Early Response Imaging After Irradiation With Cetuximab-F(ab’)2-SPECT and FDG-PET (2014) (0)
University of Groningen Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma Verhoeff, (2019) (0)
Dendritic cells labeled with In-111: In vitro and in vivo studies (1999) (0)
Electron microscopic localization of OV-TL 3-coated immunoliposomes on human ovarian carcinoma cells (1989) (0)
OC-0266: Quantitative assessment of CAIX expression with SPECT imaging in head and neck cancer xenografts (2018) (0)
41 INVITED Imaging of the microenvironment (2007) (0)
Tumor uptake and tumor retention of a monomeric and a dimeric Tc-99m-labeled RGD-peptide (2001) (0)
Specific binding of systemically administrated radiolabeled interleukin-1α (IL-1α) to type II IL-1 receptor in focal inflammation in mice (1997) (0)
EANM Springer Prizes awarded at EANM’11 (2011) (0)
Pretargeted dual-modality (SPECT/fluorescence) imaging in a carcinoembryonic antigen-expressing tumor model (2013) (0)
12 Use of Radiolabeled Liposomes for Imaging of Infection and Inflammation (0)
Comparative study of Adrenal Fast Track and Enhanced Recovery (AFTER) protocol for retroperitoneoscopy in patients with primary aldosteronism (2021) (0)
CMR 2005: 9.07: In vivo MR tracking of magnetically labeled dendritic cells: first clinical experience (2006) (0)
Radioimmunotherapy of cancer with Lu-177 labeled monoclonal antibodies and bispecific antibodies (2005) (0)
389 Dual modality imaging of clear cell renal cell carcinoma using dual-label anti-Carbonic Anhydrase IX antibody 111Indium-G250-IRDye800CW (2014) (0)
297 Diffusion weighted MRI to discriminate the histological subtype of renal tumours (2016) (0)
In vivo imaging using liposomal phage display peptide derivates targeting integrins in activated leucocytes (2005) (0)
I NTRAVENOUSLY ADMINISTERED SI RNA ACCUMULATES IN THE KIDNEY AND SELECTIVELY SUPPRESSES GENE FUNCTION IN RENAL PROXIMAL TUBULES (2006) (0)
Imaging experimental intra-abdominal abscesses with technetium-99m-PEG-liposomes and technetium-99m-HYNIC-immunoglobulin G (1998) (0)
Molecular Imaging of Infection and Inflammation (2003) (0)
and 111 In-labelled minigastrin (2008) (0)
PL - 92. Non-invasive determination of the beta cell mass in rats by SPECT with In-111-DTPA-Exendin-3 (2011) (0)
A Novel 111 In-labeled Anti-PSMA Nanobody for Targeted SPECT / CT Imaging of Prostate Cancer (2015) (0)
Radioimmunotherapy of renal cell carcinoma with chimeric monoclonal antibody G250. (1999) (0)
Multi-step targeting of renal cell carcinoma with anti-RCC x anti-DTPA bispecific monoclonal antibodies (1997) (0)
Quantitative in vivo 19 F MRI of transplanted pancreatic islets using clinically applicable , non-emulsion nanoparticles (2011) (0)
Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity (2020) (0)
Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan (2017) (0)
Development of ELISAs for Quantification of HMFG1-Specific Human Anti-Mouse IgG and IgM Antibodies (2007) (0)
Central delivery of iodine-125–labeled cetuximab, etanercept and anakinra after perispinal injection in rats: possible implications for treating Alzheimer’s disease (2015) (0)
Abstract A36: ImmunoSPECT and ImmunoPET imaging of IGF-1R expression in a model for triple negative breast cancer (2010) (0)
Pretargeting of prostate cancer with an internalizing anti-EGP-1 x anti-HSG bispecific antibody (2011) (0)
Peritoneal Carcinomatosis of Colorectal Origin: Standard of Care (2006) (0)
35 oral: FLT-PET-CT for Early Treatment Response Monitoring in Head and Neck Tumours (2010) (0)
Optimization of fluorescently-labeled antibodies for image-guided surgery (2014) (0)
In vivo imaging of changes in IGF-1R expression in a hormone-responsive breast cancer mouse model (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Otto C. Boerman?

Otto C. Boerman is affiliated with the following schools:

Otto C. Boerman's Academic­Influence.com Rankings

Why Is Otto C. Boerman Influential?

Otto C. Boerman's Published Works

Published Works

What Schools Are Affiliated With Otto C. Boerman?

Otto C. Boerman's AcademicInfluence.com Rankings